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Abstract
Background: There is currently no consensus from the relevant stakeholders regarding the operational and construct
definitions of child assent for research. As such, the requirements for assent are often construed in different ways,
institutionally disparate, and often conflated with those of parental consent. Development of a standardized
operational definition of assent would thus be important to ensure that investigators, institutional review boards, and
policy makers consider the assent process in the same way. To this end, we describe a Delphi study that provided
consensus from a panel of expert stakeholders regarding the definitions of child assent for research.
Methods: Based on current guidelines, a preliminary definition of assent was generated and sent out for review to a
Delphi panel including pediatric bioethicists and researchers, Institutional Review Board members, parents, and
individuals with regulatory/legal expertise. For each subsequent review, the process of summarizing and revising
responses was repeated until consensus was achieved. Panelists were also required to rank order elements of assent
that they believed were most important in defining the underlying constructs of the assent process (e.g., capacity for
assent, disclosure). In providing these rankings, panelists were asked to frame their responses in the contexts of
younger (≤ 11 yrs) and adolescents/older children (12-17 yrs) in non-therapeutic and therapeutic trials. Summary
rankings of the most important identified elements were then used to generate written construct definitions which
were sent out for iterative reviews by the expert panel.
Results: Consensus regarding the operational definition was reached by 14/18 (78%) of the panel members.
Seventeen (94%) panelists agreed with the definitions of capacity for assent, elements of disclosure for younger
children, and the requirements for meaningful assent, respectively. Fifteen (83%) members agreed with the elements of
disclosure for adolescents/older children.
Conclusions: It is hoped that this study will positively inform and effect change in the way investigators, regulators,
and IRBs operationalize the assent process, respect children’s developing autonomy, and in concert with parental
permission, ensure the protection of children who participate in research.
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Background
While research participation for most children requires
the permission of parent(s)/guardian(s), the bioethical
principle of “respect for persons” requires that children
also provide their assent to participate to the degree that
they are deemed “capable of providing it,” taking into ac-
count the child’s “age, maturity, and psychological state”
(45CFR46.608a) [1]. While this regulatory framework is
designed to allow children to express their burgeoning
autonomy, foster moral growth, and develop decision-
making skills, it provides absolutely no practical guid-
ance with respect to what actually constitutes assent and
which children are capable of providing it [2, 3]. Indeed,
Unguru et al. wrote: “Despite significant progress there
is still considerable disagreement surrounding many fun-
damental components of assent. No consensus exists in
guidelines, as disseminated by the federal government,
professional associations, or by the assent community
[4].” Because of this lack of consensus, the requirements
* Correspondence: atait@umich.edu
1Departments of Anesthesiology, University of Michigan Health System, 1500
E. Medical Center Drive, Ann Arbor, MI 48109, USA
3Center for Bioethics and Social Sciences in Medicine, University of Michigan
Health System, 1500 E. Medical Center Dr, Ann Arbor, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Tait and Geisser BMC Medical Ethics  (2017) 18:41 
DOI 10.1186/s12910-017-0199-4
for assent (e.g., how capacity for assent should be assessed,
what information children actually want, and what should
be disclosed) are often construed in different ways, institu-
tionally disparate, and often inappropriately conflated with
those of parental consent [5, 6].
Federal guidelines (45CFR46.102a) [1] define Assent as
“a child’s affirmative agreement to participate in research”
which does not take into consideration the complexity of
the assent process. Furthermore, because there is no con-
sensus regarding the definition of assent, individual IRBs
often apply different standards for assent [7]. For example,
arbitrary age-thresholds are often used as proxy measures
of children’s ability to assent. While one could argue that
an age-based approach protects children from their own
lack of experience, it has the potential to ignore the child’s
cognitive and psychosocial features [8]. Indeed, children’s
understanding of research information can be highly vari-
able across and even within age groups [9]. Recent work
however suggests that age explains most of the variance in
children’s capacity to consent and that some children over
the age of 12 years may be capable of providing their own
consent [10, 11]. However, because not all children are lit-
tle adults, one cannot hold them to the same standards as
those of their parents and, as such the requirements for
assent must be viewed independently from consent.
In an attempt to provide greater standardization of the
assent process, this study was designed to seek consen-
sus from relevant stakeholders with respect to develop-
ing a single, concise operational definition of child assent
for research. We were also interested in obtaining con-
sensus definitions of the underlying constructs of assent
as applied to younger and adolescent/older children in
both therapeutic and non-therapeutic trials.
Methods
Delphi has been described as “… a structured process
for collecting and distilling knowledge from a group of
experts by means of a series of questionnaires interspersed
with controlled opinion feedback [12],” and has been used
extensively in public health as means of obtaining expert
consensus [13]. This study was deemed exempt by the
University of Michigan’s Institutional Review Board (IRB).
Conducted from September 2015 to May 2016, the study
consisted of 3 phases:
Phase 1: Selecting the expert panel
Since the goal of a Delphi panel is to elicit a variety of
informed viewpoints we sought expert input from
pediatric researchers, IRB members, bioethicists, parents,
and individuals with pediatric regulatory/legal expertise.
Expertise was determined by peer-reviewed publications,
memberships in professional societies, IRBs, regulatory
bodies, and parent/child advocacy groups [12]. We
included both sexes, minorities (if known), and members
from geographically different regions.
Consent to participate was obtained via e-mail. Partici-
pants were informed of the voluntary nature of the study
and assured that their names would not be revealed to
any of the other panel members until publication of the
study. Final publication and sharing of the identities of
the panel members required written permission.
Phase 2: Generation of a preliminary operational
definition of assent
We first performed a literature review of current national
and international definitions of assent including, among
others, the Code of Federal Regulations [1] the American
Academy of Pediatrics [14] and the Royal College of
Paediatrics and Child Health [15]. Literature reviews were
based on searches using MEDLINE/PubMed and Google
Scholar. Based on these reviews, we generated a prelimin-
ary operational definition that was presented for consider-
ation to the expert panel.
Phase 3: Round 1 reviews
Each potential Delphi member was sent e-mail instruc-
tions regarding expectations and roles. The e-mail also
contained the preliminary operational definition together
with a brief questionnaire containing four open-ended
statements based on the Delphi study of consent compre-
hension by Buccini et al. [16]:
a) “The elements of the proposed definition that I
agree with include …”
b) “The elements of the proposed definition that I did
not agree with include …”
c) “I feel the following elements are essential to retain
or add to the proposed definition …”
d) “My suggestions for modifying or changing the
definition are as follows …”
Each panelist’s responses were e-mailed back to the prin-
cipal investigator, de-identified on receipt and analyzed an-
onymously, thereafter. Responses were scrutinized by both
authors to identify common themes using standard quali-
tative techniques i.e., identifying repetitions, similarities
and differences. Up to 2 e-mail reminders were sent in the
event that a review was not completed within the specified
time frame.
Iterative reviews
a) Operational Definition: For each round, the process
outlined above of collecting, summarizing, analyzing,
and revising panelists’ responses was repeated. At the
point wherein the definitions appeared to coalesce, a call
for consensus (>75% agreement) was initiated.
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b) Constructs definitions: We were also interested in
obtaining consensus on the underlying constructs of
assent e.g., assessment of capacity, disclosure, etc. Because
such constructs likely differ depending on the develop-
mental level of the child and the type of study e.g., non-
therapeutic vs therapeutic, we asked panelists to consider
each definition within these contexts.
Given that it would be impossible to establish individual
definitions for all age and developmental levels, for the
purposes of this study, we asked panelists to consider chil-
dren above and below 11 years. While we do not necessar-
ily agree with age-cut-offs per se, our rationale for this
“developmental” cut-off was that it corresponds well with
established beliefs regarding when children transition
from concrete to operational thought [17]. Adolescents
begin to understand and develop the ability to act from
moral motivations at 11-12 years of age [18] and some
may also be capable of providing their own consent [10].
Furthermore, studies have shown that children’s under-
standing of research information improves significantly
after this age [9, 19].
We selected 3 constructs including assessment of cap-
acity, information disclosure, and requirements for mean-
ingful assent [20, 21]. For each construct, we generated a
list of elements that best describe these constructs. Panel-
ists were asked to review these elements and then rank
each in order of importance (0-100, where 100 = highest
importance). The total value of the rankings had to equal
100. For example, for the disclosure construct, panelists
were required to rank order risks, procedures, benefits,
etc. in the contexts of a child vs adolescent/older child in
both a therapeutic and non-therapeutic trial. Summary
rankings of the most important elements were then used
to generate written definitions which were sent out for it-
erative reviews by the expert panel.
Sample size and statistical analysis
Since the basis for selecting the size of a Delphi panel is not
a statistical one, conventional power analyses are not relevant
[12]. The literature, however, suggests that Delphi projects
can be adequately performed with panels of 8-15 experts
over 3-4 rounds [22]. Although increasing the sample size
can reduce group error somewhat, there is a threshold be-
yond which increasing the numbers provides only marginal
benefit [12]. Furthermore, large panels can become unwieldy
and increase the time to consensus. Based on these criteria,
our panel of 20 experts would be considered large by most
Delphi standards [22]. Open-ended questions were analyzed
thematically, as described. Quantitative scoring utilized mea-
sures of central tendency e.g., means ± SD, and medians.
Results
We generated a master list of 33 potential stakeholders
of whom 8 failed to respond and 5 responded but
declined participation. Of the original pool, 20 agreed to
participate. This initial panel comprised of experts in
pediatric research (n = 11), IRB/regulatory affairs (7),
bioethics (9), legal (3), and combinations thereof. Eleven




Based on our synthesis of the current definitions of assent
we formulated a preliminary definition of assent retaining
some core elements from 45CFR46 [1] as follows:
“An interactive process between a researcher and child
participant involving developmentally appropriate
disclosure, discussion, and understanding wherein the
child freely affirms their agreement to participate in a
proposed research study but has insufficient maturity
or lack of legal authority to meet the formal and legal
expectations of informed consent. In the absence of an
affirmative agreement, mere failure of the child to
object should not be construed as assent.”
Round 1 reviews
Nineteen of 20 (95%) panelists responded to this prelimin-
ary definition. Terms considered important by the majority
included “interactive process,” “developmentally appropri-
ate” and, “affirmative agreement.” A voiced concern was
that this definition did not adequately describe what should
be disclosed and what the child might expect from the
study. Based on themes identified in this first round, a re-
vised definition was generated (see Additional file 1).
Round 2 reviews
Thirteen of 20 (68.4%) responded to the first revision.
Of concern was the use of the term “free of any outside in-
fluence” since parents often exert influence over their
child’s decision-making that may not be inherently bad.
The revised version from this round is shown in Additional
file 1.
Round 3 reviews
Seventeen of 20 members (85%) responded to the second
revision. A primary concern was the term “must” provide
assent. Suggestions were to replace this with “should” and
provide caveats under which assent “should” be sought.
Others remarked that “what they might expect” was too
vague and that children should understand how they
might experience what will happen to them e.g., burden/
discomfort. The expectations that assent decisions should
be “reasonable” and “rational” was eliminated since it was
thought to set too high a standard for children. From
these comments, a revised version was sent for review
(see Additional file 1).
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Final round reviews
In the final round, 2 panel members were dropped due
to loss to follow-up. Eighteen of 18 (100%) members
responded to the third revision. At call for consensus,
14/18 (78%) panelists agreed with the operational defin-
ition of assent as written. While 2 of the “dissenters” re-
ported that they agreed conceptually with the definition,
both suggested minor revisions that were not shared by
the majority and thus were not re-negotiated. One mem-
ber disagreed but offered no justification (we believe that
this may have been an error since there were no other
indications to suggest disagreement, however, we cannot
be certain). Only one member disagreed conceptually
believing that the definition held older children to a
higher standard. The final version is shown here:
“Children who lack the legal authority to provide
informed consent per state laws should provide their
assent to participate in a research study unless they
either lack the cognitive ability, their clinical condition
precludes their ability to communicate a choice, or the
research holds out the prospect of direct benefit that is
only available in the context of the research. Assent is
an interactive process between a researcher and child
participant involving disclosure of cognitively and
emotionally appropriate information regarding, at
minimum, why the child is being asked to participate,
a description of the procedures and how the child
might experience them, and an understanding that
participation in the study is voluntary. Children
should understand that they can decline participation
or withdraw from the study at any time. Assent
requires that the child explicitly affirms his or her
agreement to participate in a manner that reflects
their age-appropriate understanding and that is free of
undue influence or coercion. In the absence of an explicit
agreement, mere failure of the child to object cannot be
construed as assent.”
Construct definitions
The ranked elements for each of the assent constructs
are presented in Table 1. For analysis, we chose a me-
dian ranking cut-point of 10 as the demarcation between
elements deemed least and most important. While this
did not preclude inclusion of elements below this cut-
point we used the most important identified elements to
generate 4 initial construct definitions of assent i.e., as-
sessment of capacity, disclosure for younger and older
children, and requirements for meaningful assent [23].
These initial definitions underwent 2 further revisions by
the panel (see Additional file 2).
Seventeen (94%) panelists agreed with the final defini-
tions of capacity for assent, information disclosure for
younger children, and the components of meaningful
assent, respectively. Fifteen (83%) members agreed with
the information disclosure for adolescents/older children.
The final consensus versions of each of these constructs
are shown below.
Assessment of child capacity
Assessment of the general development of the child can
typically be accomplished through a discussion with either
the child alone or together with a parent or legal guardian
to gauge maturity/cognitive ability. Consideration should
be given to the child’s current health status and any prior
decision-making experiences. Assessment should employ a
“teach back” method to assess developmentally appropriate
understanding of the study information. In cases in which
capacity is in doubt, it may be appropriate to involve a
child-behavioral specialist.
Information for younger children (7-11 yrs)
If assent is deemed appropriate, younger children should,
at minimum, be told what procedures will be done and
how the child might experience them, the purpose of the
study, that there may be no expectation of personal benefit
but that their participation may help other children, that
the study is voluntary, and that they can withdraw at any
time.
Information for older children/adolescents (12-17 yrs)
At minimum, older children and adolescents should be
told what procedures will be done and how they might
experience them, the purpose of the study, that there may
be no expectation of personal benefit but that their
participation may help other children, that the study is
voluntary, and that they can withdraw at any time. In
some cases, it may appropriate for the investigator to
speak with the child or adolescent absent from his or
her parent(s) or legal guardian(s). For some therapeutic
trials it is important that older children and adolescents
be told that the research may be different from standard
clinical care in their situation.
Requirements for meaningful assent (younger and older
children definitions were collapsed)
If assent is deemed appropriate, children should under-
stand the basic study-specific information, should have a
developmentally appropriate awareness of their condition,
and be able to appreciate, at a rudimentary level, how the
information applies to their own situation. Children should
be free to decide whether or not to participate in a study
and articulate their choice absent of any undue influence
or coercion.
Discussion
Child assent serves as an important protection for chil-
dren in research [24] however, the current regulations
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Table 1 Summary of Rankings
Assessment of child capacity
Assessment Ranking
Mean ± SD (Median)
Discussion with both the parent(s) and
child to gauge maturity/cognitive ability
20.33 ± 15.8 (30.0)
Employ “teach back” (feedback) to assess
understanding
18.67 ± 20.00 (20.0)
Discussion with the child only to gauge
maturity/cognitive ability
12.33 ± 11.3 (10.0)
Based on general developmental level e.g.,
child versus adolescent
11.67 ± 11.4 (10.0)
Based on age cut-offs: (please specify) 9.00 ± 10.2 (5.0)
Employ a short quiz to determine level of
understanding
7.67 ± 10.3 (0.00)
Assessment based on a formal standardized
tool e.g., MacCAT-CR
6.00 ± 9.3 (0.0)
Discussion with the parent(s) only to gauge
maturity/cognitive ability
3.00 ± 4.6 (0.0)
Disclosure: Non-therapeutic trial-younger children (7-11 yrs)
Elements Ranking
Mean ± SD (Median)
What will be done (the procedures) 22.56 ± 4.6 (20.0)
That the study is voluntary 16.79 ± 7.2 (20.0)
That they can withdraw at any time 14.49 ± 7.7 (15.0)
Purpose of the study 11.77 ± 7.7 (10.0)
Benefits to the child 6.92 ± 5.9 (10.0)
Risks 6.92 ± 6.9 (5.0)
Benefits to others 5.00 ± 5.0 (5.0)
That the research is different from clinical
care
4.00 ± 5.9 (0.0)
Alternatives 3.31 ± 3.7 (3.0)
They do not need to understand, parental
permission is sufficient
1.92 ± 3.8 (0.0)
That their information will remain confidential 0.92 ± 1.9 (0.0)
Level of discomfort or effort required 20.0 ± 0.0 (20.0) n = 1
Disclosure: Non-Therapeutic trial-older children (12-17 yrs)
Elements Ranking
Mean ± SD (Median)
What will be done (the procedures) 17.46 ± 6.8 (15.0)
That the study is voluntary 13.07 ± 4.3 (10.0)
Purpose of the study 13.06 ± 5.9 (10.0)
That they can withdraw at any time 11.15 ± 5.1 (10.0)
Risks 10.9 ± 4.9 (10.0)
That the research is different from clinical care 7.69 ± 5.6 (10.0)
Benefits to the child 7.61 ± 3.8 (10.0)
Benefits to others 7.07 ± 4.5 (10.0)
That their information will remain confidential 6.15 ± 5.8 (5.0)
Alternatives 5.00 ± 3.5 (5.0)
Table 1 Summary of Rankings (Continued)
They do not need to understand, parental
permission is sufficient
0.00 ± 0.00 (0.00)
Level of discomfort or effort required 10.0 ± 0.00 (10.0) n = 1
Disclosure: Therapeutic trial-younger children (7-11 yrs)
Elements Ranking
Mean ± SD (Median)
What will be done (the procedures) 21.25 ± 8.3 (20.0)
Purpose of the study 13.31 ± 8.4 (15.0)
That the study is voluntary 12.41 ± 9.2 (10.0)
That they can withdraw at any time 12.18 ± 10.0 (10.0)
They do not need to understand, parental
permission is sufficient
8.08 ± 20.7 (0.0)
Risks 7.46 ± 6.1 (5.0)
Benefits to the child 7.08 ± 5.7 (5.0)
Alternatives 5.00 ± 4.0 (5.0)
That the research is different from clinical care 5.00 ± 6.5 (0.0)
Benefits to others 3.08 ± 3.8 (0.0)
That their information will remain confidential 1.69 ± 3.1 (0.0)
Disclosure: Therapeutic trial-older children (12-17 yrs)
Elements Ranking
Mean ± SD (Median)
What will be done (the procedures) 17.46 ± 7.6 (17.0)
Purpose of the study 13.84 ± 5.8 (10.0)
That they can withdraw at any time 12.08 ± 5.9 (10.0)
That the study is voluntary 11.38 ± 5.6 (10.0)
Risks 11.2 ± 4.6 (10.0)
That the research is different from clinical care 8.84 ± 5.8 (10.0)
Benefits to the child 7.69 ± 3.9 (10.0)
Alternatives 6.38 ± 3.6 (5.0)
Benefits to others 5.38 ± 4.8 (5.0)
That their information will remain confidential 3.85 ± 3.6 (5.0)
They do not need to understand, parental
permission is sufficient
0.00 ± 0.0 (0.0)
Level of discomfort or effort required 10.0 ± 0.00 (10.0) n = 1
Requirements for meaningful assent: younger children (7-11 yrs)
Ranking
Mean ± SD (Median)
Child should understand the basic information 24.23 ± 10.4 (25.0)
Child should have a developmentally
appropriate awareness of their condition
18.84 ± 8.9 (20.0)
Child should be able to appreciate
the information (i.e., apply the
information to their own situation)
13.84 ± 8.2 (15.0)
Decisions should be free of any
external pressure or expectations
13.84 ± 13.6 (10.0)
Child should be able to articulate
an unambiguous choice
10.77 ± 6.1(10.0)
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offer no single standardized operational definition of
assent and no guidance regarding which children may be
capable of providing it [21]. Importantly, there have also
been no systematic efforts to define the constructs of
assent. Indeed, Sibley et al. [25] wrote: “The definition,
purpose or scope of assent (like the interpretation of
dissent) remains woefully ill-defined.” To this end, we
convened a panel of expert stakeholders who through it-
erative review reached consensus on several important
definitions of assent for research. To our knowledge this
is the first study to attempt to standardize the definition
of assent using this approach. While we fully acknow-
ledge that the information in our operational definition
is not necessarily novel in that it can be sourced from a
review of the extant literature, our aim was to provide a
single concise statement that incorporated the important
elements of the assent process not addressed in the
current definitions.
While the most widely adopted definition of assent as
a child’s “affirmative agreement” is fundamentally cor-
rect, it lacks details regarding the circumstances under
which assent should be sought and details of what
information should be conveyed and understood. This
has likely led to the lack of consensus among stake-
holders which as Sibley et al. suggest may in part be due
to the fact that: “the fundamental justification for the
assent process is misunderstood” [3]. While the trad-
itional approach has been how to involve parents and
children in the assent process, these authors argue that a
primary goal should be to respect children by recogniz-
ing their moral worth and helping them become better
decision-makers [3].
Delphi has several advantages over conventional quali-
tative methods i.e., inexpensive, avoids meeting logistics,
decreases group think, the bandwagon effect, and disputes
between personalities with widely disparate view-points
[12]. Relevant to this study, Buccini et al. and Geisser et al.
used Delphi to define the constructs of consent compre-
hension [16] and to establish the dimensions of ethics/IRB
review, respectively [23]. For this study, we used the Del-
phi approach to build upon our original conceptualization
and definitions of assent. Although the central theme of
“affirmative agreement” was retained, each round of re-
views added context with respect to the importance of
assent as an “interactive” process, the circumstances in
which assent should be sought, the need for age-
appropriate disclosure, and the importance for children to
understand their role and rights in a clinical trial.
The amount and type of information to be disclosed to
children of different ages/maturity have not previously
been well described. This study provided some insight into
which elements of disclosure are deemed most important
but also reinforced the importance of age-appropriate dis-
closure that takes into consideration the cognitive and
emotional maturity of the child. As Hein et al. has shown,
some children over the age of 12 years may be capable of
providing their own consent for research but due to the
inherent variability in maturity levels, the type and
amount of information disclosed and the assessment of
capacity should be considered on a case by case basis [10].
Of note, was that although we had originally included the
“risks” of research participation as an important element
of disclosure, the panel chose to rephrase this to reflect
how the child might experience the risks rather than risks
per se. We believe that this better reflects the way in
which children often perceive risks i.e., as a burden: will it
hurt and/or how might this affect me; will it keep me away
from my usual activities and friends?
Although it may not be possible to cover all the nu-
ances of assent or the many circumstances under which
it may be sought within a single definition, we attempted
to examine assent within the contexts of different age/
maturity levels and potential risk profiles. Interestingly,
it became quite evident that definitions of assent within
these contexts had more common themes than disparate
and, as such, could be collapsed into single definitions.
Table 1 Summary of Rankings (Continued)
Child should be able to reason
(i.e., able to incorporate
information with personal priorities
and potential consequences)
6.54 ± 6.6 (5.0)
Decisions must be reasonable
and rational
3.08 ± 4.8 (0.0)
Child should understand the
concept of altruism
1.92 ± 3.3 (0.0)
Requirements for meaningful assent: older children (12-17 yrs)
Ranking
Mean ± SD (Median)
Child should understand the basic
information
22.23 ± 10.6 (20.0)
Child should be able to appreciate
the information (i.e., apply the
information to their own situation)
15.88 ± 4.5 (17.5)
Child should have a developmentally
appropriate awareness of their
condition
14.53 ± 5.6 (10.0)
Child should be able to articulate
an unambiguous choice
13.84 ± 5.5 (10.0)
Decisions should be free of any
external pressure or expectations
11.92 ± 8.3 (10.0)
Child should be able to reason
(i.e., able to incorporate information
with personal priorities and
potential consequences)
9.62 ± 6.91 (10.0)
Decisions must be reasonable and
rational
5.11 ± 6.0 (5.0)
Child should understand the concept
of altruism
3.00 ± 4.6 (3.0)
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Limitations of this approach are recognized. First, our
study represents the views from one group of experts
interpreted by one group of investigators, and while it is
likely that another similarly expert panel would arrive at
similar conclusions, we cannot be certain. Second, be-
cause we believed it important to understand how the
definitions might change with maturity level, we chose
11 years as a developmental cut-point. Although we jus-
tify this cut-point, it can only be considered a surrogate
assessment of maturity and, as such, the results should
be interpreted accordingly. Third, while Delphi offers
several advantages, it does not allow for in-depth discus-
sions. We should note however, that we were encouraged
by the depth and detail of the many individual viewpoints.
Furthermore, while thematic analysis highlighted the most
salient points, items that did not fit a common theme may
have been excluded in the definitions offered for review.
Thus, while we made every attempt to include as many
themes that we believed to be relevant, we acknowledge
that it is almost impossible within any single definition to
account for all the circumstances under which assent is
sought and that aligns perfectly with everyone’s views and
beliefs. Our final definitions were thus attempts to be in-
clusive yet concise. Another potential limitation was that
while we had initially considered including children as
stakeholders in the Delphi panel, we were concerned that
children lacked the requisite ethical expertise and ability
to meaningfully complete the Delphi questionnaire and
assign relative percentage values to each of the elements.
Finally, although we had sought input from experts out-
side of the US, unfortunately, none responded. While we
believe that our definitions could be relevant outside of
the US, additional studies may be warranted.
Conclusions
While we acknowledge that not all definitions can be all
things to all people, we hope that our proposed
consensus-driven definitions will inform a more compre-
hensive and practical characterization of the assent
process compared with current definitions and serve as
a platform for further discussion and thought. Although
this study is focused on assent for research, we also
believe that the results have important implications for
the way in which clinical assent is defined and
operationalized. We hope therefore, that in providing
a single operational definition of assent that incorpo-
rates elements deemed most important by stake-
holders that we may be able to positively inform the
way in which investigators, regulators, and IRBs
operationalize the assent process, respect children’s
developing autonomy and decision-making skills, and
in concert with parental permission, ensure the pro-
tection of children participating in research.
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